Tower Research Capital (TRC)’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.6K | Buy |
8,182
+2,523
| +45% | +$19K | ﹤0.01% | 2791 |
|
|
2025
Q1 | $42.8K | Sell |
5,659
-3,141
| -36% | -$23.8K | ﹤0.01% | 2329 |
|
|
2024
Q4 | $107K | Buy |
8,800
+7,079
| +411% | +$86.2K | ﹤0.01% | 2114 |
|
|
2024
Q3 | $28.8K | Sell |
1,721
-2,303
| -57% | -$38.6K | ﹤0.01% | 3025 |
|
|
2024
Q2 | $70.2K | Buy |
4,024
+3,699
| +1,138% | +$64.5K | ﹤0.01% | 2843 |
|
|
2024
Q1 | $5.54K | Sell |
325
-9,909
| -97% | -$169K | ﹤0.01% | 4529 |
|
|
2023
Q4 | $104K | Sell |
10,234
-5,156
| -34% | -$52.5K | ﹤0.01% | 2619 |
|
|
2023
Q3 | $139K | Buy |
15,390
+12,330
| +403% | +$112K | ﹤0.01% | 1723 |
|
|
2023
Q2 | $32.9K | Buy |
3,060
+858
| +39% | +$9.23K | ﹤0.01% | 2920 |
|
|
2023
Q1 | $23K | Buy |
2,202
+1,002
| +84% | +$10.5K | ﹤0.01% | 3275 |
|
|
2022
Q4 | $12K | Sell |
1,200
-494
| -29% | -$4.94K | ﹤0.01% | 3690 |
|
|
2022
Q3 | $22K | Buy |
1,694
+222
| +15% | +$2.88K | ﹤0.01% | 3853 |
|
|
2022
Q2 | $19K | Sell |
1,472
-3,842
| -72% | -$49.6K | ﹤0.01% | 3835 |
|
|
2022
Q1 | $55K | Sell |
5,314
-532
| -9% | -$5.51K | ﹤0.01% | 2652 |
|
|
2021
Q4 | $90K | Buy |
5,846
+5,107
| +691% | +$78.6K | ﹤0.01% | 2295 |
|
|
2021
Q3 | $17K | Sell |
739
-26
| -3% | -$598 | ﹤0.01% | 3853 |
|
|
2021
Q2 | $20K | Sell |
765
-55
| -7% | -$1.44K | ﹤0.01% | 3873 |
|
|
2021
Q1 | $34K | Buy |
+820
| New | +$34K | ﹤0.01% | 3442 |
|